TLTFF (Theralase Technologies) Change In Inventory : $0.08 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Theralase Technologies Change In Inventory?

Theralase Technologies's change in inventory for the quarter that ended in Dec. 2024 was $0.05 Mil. It means Theralase Technologies's inventory declined by $0.05 Mil from Sep. 2024 to Dec. 2024 .

Theralase Technologies's change in inventory for the fiscal year that ended in Dec. 2024 was $0.08 Mil. It means Theralase Technologies's inventory declined by $0.08 Mil from Dec. 2023 to Dec. 2024 .

Theralase Technologies's Total Inventories for the quarter that ended in Dec. 2024 was $0.38 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Theralase Technologies's Days Inventory for the quarter that ended in Dec. 2024 was 368.99.

Inventory Turnover measures how fast the company turns over its inventory within a year. Theralase Technologies's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.25.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Theralase Technologies's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 1.45.

Theralase Technologies Change In Inventory Historical Data

The historical data trend for Theralase Technologies's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Change In Inventory Chart

Theralase Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

0.21

-0.09

0.06

-0.13

0.08

Theralase Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Inventory	Get a 7-Day Free Trial															-0.09	0.03	-0.02	0.03	0.05

Theralase Technologies Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.08 Mil.

Theralase Technologies (OTCPK:TLTFF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Theralase Technologies's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.4165	/	0.103	*	365 / 4
	=	368.99

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Theralase Technologies's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.103	/	0.4165
	=	0.25

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Theralase Technologies's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.4165	/	0.288
	=	1.45

Theralase Technologies Change In Inventory Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (OTCPK:TLTFF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

TTX:Germany TLT:Canada

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc brings CLT to patients and personalized ACT to patients based on individual tissue characteristics. It is two separate reportable operating divisions; the Drug Division and the Device Division. The Drug Division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs), and activates them with proprietary and patent-pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The Device Division designs develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the Food and Drug Administration (FDA) for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions.